Abstract A023: Cell-Free DNA: A Paradigm Shift in Cancer Diagnostics and Precision Medicine
Bibliographic record
Abstract
Abstract Background Cell-free DNA (cfDNA) refers to DNA fragments that circulate freely in bodily fluids, primarily blood plasma. These fragments are released from cells via apoptosis and necrosis. Discovered in 1948, cfDNA gained clinical importance when linked to vascular dysfunction, positioning it as a promising non-invasive biomarker. Objective To highlight cfDNA's diagnostic and prognostic applications in oncology and other fields, and to examine key challenges and future directions. Methods In healthy individuals, cfDNA originates from normal cell turnover. In contrast, in diseases like cancer, circulating tumor DNA (ctDNA)—a subset of cfDNA—originates from tumor cells and contains mutations such as point mutations, rearrangements, and copy number variations. These genetic alterations reflect the primary tumor, allowing cfDNA analysis to guide clinical decision-making. Results In cancer, cfDNA enables early detection, therapy monitoring, tumor evolution tracking, and residual disease assessment. It also plays a role in prenatal screening, transplant rejection monitoring, and detecting infectious and cardiovascular conditions. Its short half-life (15 minutes to 2.5 hours) offers dynamic, real-time monitoring. However, low cfDNA concentrations, technical limitations (e.g., background noise, sequencing errors), and high costs in low-resource settings pose significant challenges. Detection methods like digital PCR and NGS are essential but expensive. Standardization issues in protocols and ethical concerns regarding genetic privacy further complicate adoption. Conclusion cfDNA represents a transformative tool in precision medicine. Technological advances, integration with AI, and combining cfDNA with other biomarkers could enhance sensitivity and specificity. As clinical validation progresses and protocols standardize, cfDNA testing is expected to become routine, improving early disease detection and patient outcomes. Citation Format: Mohamed Tharwat. Kamouna. Cell-Free DNA: A Paradigm Shift in Cancer Diagnostics and Precision Medicine [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities; 2025 Dec 10-13; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(23_Suppl):Abstract nr A023.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.013 | 0.012 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.001 | 0.007 |
| Scholarly communication | 0.006 | 0.007 |
| Open science | 0.002 | 0.004 |
| Research integrity | 0.008 | 0.010 |
| Insufficient payload (model declined to judge) | 0.011 | 0.006 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".